Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Updated results.

被引：3
|
作者：
Makker, Vicky
Rasco, Drew W.
Vogelzang, Nicholas J.
Messing, Mark
Brose, Marcia S.
Cohn, Allen Lee
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.5596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5596
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: Updated results
    Makker, Vicky
    Rasco, Drew
    Vogelzang, Nicholas J.
    Messing, Mark
    Brose, Marcia S.
    Cohn, Allen L.
    Aghajanian, Carol
    Stepan, Daniel E.
    Dutcus, Corina
    Schmidt, Emmett
    Guo, Matthew
    Sachdev, Pallavi
    Shumaker, Robert
    Young, Louise
    Taylor, Matthew
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 175 - 175
  • [2] Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer
    Makker, Vicky
    Taylor, Matthew H.
    Aghajanian, Carol
    Oaknin, Ana
    Mier, James
    Cohn, Allen L.
    Romeo, Margarita
    Bratos, Raquel
    Brose, Marcia S.
    DiSimone, Christopher
    Messing, Mark
    Stepan, Daniel E.
    Dutcus, Corina E.
    Wu, Jane
    Schmidt, Emmett V.
    Orlowski, Robert
    Sachdev, Pallavi
    Shumaker, Robert
    Casado Herraez, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (26) : 2981 - 2992
  • [3] Lenvatinib plus pembrolizumab in patients with renal cell carcinoma: Updated results.
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew W.
    Taylor, Matthew H.
    Stepan, Daniel E.
    Shumaker, Robert Charles
    Schmidt, Emmett V.
    Guo, Matthew
    Dutcus, Corina E.
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Lenvatinib Plus Pembrolizumab for Advanced Endometrial Cancer
    Van Le, Linda
    [J]. OBSTETRICAL & GYNECOLOGICAL SURVEY, 2022, 77 (05) : 275 - 276
  • [5] Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
    Makker, V
    Colombo, N.
    Casado Herraez, A.
    Santin, A. D.
    Colomba, E.
    Miller, D. S.
    Fujiwara, K.
    Pignata, S.
    Baron-Hay, S.
    Ray-Coquard, I
    Shapira-Frommer, R.
    Ushijima, K.
    Sakata, J.
    Yonemori, K.
    Kim, Y. M.
    Guerra, E. M.
    Sanli, U. A.
    McCormack, M. M.
    Smith, A. D.
    Keefe, S.
    Bird, S.
    Dutta, L.
    Orlowski, R. J.
    Lorusso, D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (05): : 437 - 448
  • [6] Pembrolizumab plus lenvatinib for all advanced endometrial cancer? Maybe not
    Paulino, Eduardo
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 (04) : 579 - 579
  • [7] Lenvatinib plus Pembrolizumab in advanced Endometrial Carcinoma
    Lorenz, Judith
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (05) : 464 - 464
  • [8] Lenvatinib plus pembrolizumab in patients with renal cell carcinoma: Updated results
    Lee, Chung-Han
    Makker, Vicky
    Rasco, Drew
    Taylor, Mathew
    Stepan, Daniel E.
    Shumaker, Robert
    Schmidt, Emmett V.
    Guo, Matthew
    Dutcus, Corina
    Young, Louise
    Motzer, Robert
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 174 - 175
  • [9] Pembrolizumab Plus Lenvatinib Approved in Advanced Endometrial Carcinoma
    Schuyler, Devon
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 610 - 610
  • [10] Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab
    Colombo, Nicoletta
    Lorusso, Domenica
    Monk, Bradley J.
    Slomovitz, Brian
    Hasegawa, Kosei
    Nogueira-Rodrigues, Angelica
    Zale, Melissa
    Okpara, Chinyere E.
    Barresi, Gianmaria
    McKenzie, Jodi
    Makker, Vicky
    [J]. ONCOLOGIST, 2024, 29 (01): : 25 - 35
12345